Best Health and Medical Grants in New York

The Limited Competition: Ruth L. Kirschstein National Research Service Award (NRSA) Institutional Research Training Grant aims to enhance clinical and translational science training by supporting programs that prepare predoctoral and postdoctoral researchers. This initiative, funded by the NIH, focuses on translating scientific discoveries into effective health interventions. Eligible institutions will be invited to apply, and only high-quality applications will be considered for funding, ensuring a robust peer-review process.

The Limited Competition: Institutional Mentored Research Career Development Program aims to enhance the CTSA Program by fostering the development of postdoctoral fellows and junior faculty. This initiative focuses on training individuals for independent clinical and translational science careers, ensuring they are well-prepared for research engagement. Funded by the NIH, the program supports a national network of academic centers to facilitate the transition of scientific discoveries into practical health solutions.

The Clinical and Translational Science Award (CTSA) Program aims to enhance the translation of scientific research into effective health interventions by establishing a national network of academic medical centers. This program supports integrated research and training environments for clinical and translational science, promoting the development of innovative methods and technologies. The reissuance of the CTSA Notice of Funding Opportunity invites eligible organizations to apply, with peer-reviewed applications prioritized for funding.

The "Opportunities for Collaborative Research with the NIH Intramural Research Program (U01 Clinical Trial Optional)" aims to foster partnerships between NIH intramural and extramural researchers. This initiative supports translational research projects that bridge basic biological discoveries and clinical applications, enhancing health outcomes. By encouraging collaborations, it seeks to accelerate the development of new therapies and prevention strategies, leveraging unique NIH resources to strengthen scientific innovation and address critical disease processes.

Research institutions and organizations studying health workforce needs in the U.S., including New York, can apply for the Health Workforce Research Center program, with awards of US $450,000 - US $900,000 for research activities. Funded by the Health Resources & Services Administration, projects must inform federal, state, or local decision-makers about health and medical workforce issues.

The NIH Common Fund is planning to issue a NOFO to continue the Bridge2AI program, which aims to develop AI-ready datasets and best practices for biomedical research. This next stage will leverage these datasets to address significant health challenges and foster multidisciplinary collaboration. The initiative will support 3-5 Centers focused on trustworthy AI in biomedical research, creating frameworks for reproducibility, transparency, and advancing the AI workforce in health sciences.

The NIDDK Disease Research and Translational Core Centers (P30 Clinical Trial Optional) program invites applications to support innovative biomedical research focused on cystic fibrosis, diabetes, and other chronic diseases. These centers foster collaboration, provide essential resources, and mentor early-stage investigators, enhancing the research landscape. Funding will support pilot programs and access to shared services, ensuring efficient use of resources while promoting a robust scientific community dedicated to advancing health outcomes.

The National Institutes of Health (NIH) is set to announce a Notice of Funding Opportunity (NOFO) for multi-site investigator-initiated clinical trials. This initiative aims to support a range of clinical trials addressing efficacy and implementation research. The funding mechanism includes a two-phase approach (UG3/UH3), with a total award duration of up to seven years. Investigators are encouraged to prepare proposals that demonstrate scientific rationale and operational plans for these important studies.

About Us

Alpha Omega Alpha, founded in 1902, is the national medical honor society. Its mission is: dedicated to the belief that in the profession of medicine we will improve care for all by:

• recognizing high educational achievement;
• honoring gifted teaching;
• encouraging the development of leaders in academia and the community;
• supporting the ideals of humanism; and
• promoting service to others.

Medical Student Service Leadership Project Grant

AΩA is committed to preparing future leaders in medicine and health care. Leadership is about making a positive difference and can be developed through education, observation, experience, and by working with leader mentors. Service learning provides excellent opportunities for students to develop as servant leaders. Only one team from each school may be nominated.The Grant

The grant is a $9,000, two-year grant – $5,000 the first year, and $4,000 the second year. The grant will be paid to the sponsoring institution. 

Alpha Omega Alpha Honor Medical Society

Alpha Omega Alpha, founded in 1902, is the national medical honor society. Its mission is:

• Alpha Omega Alpha — dedicated to the belief that in the profession of medicine we will improve care for all by:
• recognizing high educational achievement;
• honoring gifted teaching;
• encouraging the development of leaders in academia and the community;
• supporting the ideals of humanism; and
• promoting service to others.

Helen H. Glaser Student Essay Award

To encourage medical students to write scholarly essays relevant to medicine. Winning essays will be published in an issue of The Pharos.

Only one entry may be submitted per student.

Requirements

• Essays must be written while the student is in medical school, must be the work of a single author, and must be an original work. The essay must not be offered to, or published by, any other journal or entered in any other contest prior to submission or during, the AΩA selection process.
• The essay must be related to medicine.
• Essays should not be fictional or written in first person, but academic/scientific in theme.
• The essay must not exceed 15 double-spaced pages of 12-point type with minimum 1-inch margins, exclusive of reference listing. The author’s name and essay title must be on each page, and all pages must be numbered.
• Unique references, numbered consecutively, should be limited to 20. (Reference citation of a website is not acceptable unless a site is the sole source of the information or has official academic credentials. Examples of acceptable sites are official government web pages such as that of the National Institutes of Health.)
• The Pharos Editorial Board suggests that authors review George Orwell’s “6 Rules for Writing”.
• Essays that are not selected as award recipients may be submitted to other contests/publications after the winners are announced.
• Essays not meeting all requirements will not be considered.

The National Institute of Environmental Health Sciences (NIEHS) is launching a funding opportunity for research hubs focused on the health impacts of extreme weather. This initiative encourages multidisciplinary teams to engage with community partners on issues such as wildfire smoke and extreme heat. Emphasizing collaboration, the program aims to develop scalable solutions and measurable public health outcomes, leveraging resources and expertise across institutions to address climate-related health challenges effectively.

The NLM Grants for Scholarly Works in Biomedicine and Health (G13) program invites applications to support the creation of book-length manuscripts and scholarly works that are vital for U.S. health professionals and scientists. This initiative aims to foster critical reviews and analytical syntheses that enhance understanding of biomedical and public health challenges, ultimately contributing valuable resources for education, research, and clinical practice.

The R21 Clinical Trial Not Allowed funding opportunity invites innovative research to develop and enhance research models and biological materials vital for studying human health and diseases. It emphasizes the need for new approach methodologies (NAMs) to improve the identification of confounding factors in biomedical research. Projects should have broad applicability across multiple NIH Institutes, focusing on various body systems and disease categories, ensuring relevance to a wide range of health issues.

The National Institutes of Health (NIH) is continuing support for the Network for Excellence in Neuroscience Clinical Trials (NeuroNEXT), which focuses on clinical trials and biomarker validation studies for neurological disorders. This initiative aims to foster innovation in neurotherapeutics by providing essential infrastructure and expertise. The program encourages the establishment of Clinical Coordinating Centers (CCC) and Data Coordinating Centers (DCC) to enhance collaborative efforts. Note that applications are not currently being solicited.

The NIH Director's Transformative Research Award encourages innovative research that challenges conventional ideas. This award supports bold scientists and teams aiming to create groundbreaking technologies and new clinical approaches, ultimately transforming scientific paradigms. As part of the NIH Common Fund's High-Risk, High-Reward Research Program, it seeks to fund high-impact projects that have the potential to significantly advance science and technology.

The NIH Director's Early Independence Award empowers exceptional early-career researchers to embark on independent research careers immediately after their doctoral degree or post-graduate clinical training. This initiative accelerates the transition to independence, promoting innovative research across various fields aligned with the NIH mission. As part of the NIH Common Fund's High-Risk, High-Reward Research Program, it encourages groundbreaking studies that could significantly advance health-related knowledge.

The NIH Director's Pioneer Award (DP1) encourages innovative research by funding exceptional scientists. This award is designed for groundbreaking projects that diverge from the investigator's current work and address significant scientific challenges relevant to the NIH mission. Applications are invited across all NIH-relevant fields, promoting high-risk, high-reward research that could transform our understanding of critical scientific areas.

The NIH Director's New Innovator Award supports creative early-stage investigators pursuing innovative research with transformative potential for science relevant to the NIH mission. Applications are encouraged across all NIH-related fields, enhancing support for emerging talent. This award is part of the NIH Common Fund's High-Risk, High-Reward Research Program, which aims to cultivate groundbreaking research and foster the next generation of scientists.

About BHOF

For 40 years, the Bone Health & Osteoporosis Foundation (BHOF) has been committed to preventing osteoporosis and promoting awareness about bone health. Learn more about our organization.

Awards

Robert F. Gagel, M.D. Community Leadership Award

The Robert F. Gagel, M.D. Community Leadership Award recognizes a healthcare professional who has made outstanding contributions to improving osteoporosis care and increasing community awareness about bone health. This award will be presented annually to a healthcare professional residing and working in the United States or its territories.

The Executive Committee of the Bone Health and Osteoporosis Foundation’s (BHOF’s) Board of Trustees will review nominations and select the recipient.

The award winner will be notified and announced in May, in recognition of Osteoporosis Awareness and Prevention Month. The recipient will receive a plaque and a financial award (currently $1,000) to support community service efforts initiatives related to osteoporosis and bone health.

About Us

Our Mission

The Marfan Foundation drives research, education and support – and builds community – to improve outcomes, save lives and empower all people to thrive who are living with Marfan, Loeys-Dietz, Vascular Ehlers-Danlos syndromes, and related genetic aortic and vascular conditions.

Our Vision

Quality of life, longevity, and cures for all people with genetic aortic and vascular conditions.

Innovators Award

This is for faculty investigators for $100,000 over 2 years ($50,000 per year), to explore an innovative concept in “translational” science that has applicability to improving human health. Examples could include fundamental research, diagnostic tests, biomarkers, biomedical engineering advances, and imaging advances. Collection of data for improved evidence-based medical guidance are of great interest.

About Us

Our Mission

The Marfan Foundation drives research, education and support – and builds community – to improve outcomes, save lives and empower all people to thrive who are living with Marfan, Loeys-Dietz, Vascular Ehlers-Danlos syndromes, and related genetic aortic and vascular conditions.

Our Vision

Quality of life, longevity, and cures for all people with genetic aortic and vascular conditions.

Career Development Award

The Career Development Award will support two-year $100,000 grants ($50,000 per year) in basic, translational, or clinical research studying any discipline involved in Marfan syndrome, Loeys-Dietz syndrome, Vascular Ehlers-Danlos syndrome, and other related conditions. This grant program is designed to support investigators early in their career to derive preliminary data in a key concept area that has high potential to lead to extended funding from NIH, EU, and other large research funding sources.

The National Institute on Minority Health and Health Disparities (NIMHD) is offering funding for innovative research aimed at improving health outcomes for Native Hawaiian and Pacific Islander populations. This grant will support preparatory and pilot activities that focus on understanding health disparities, testing interventions for chronic diseases, and promoting health behavior changes in collaboration with community partners. Projects should address critical health issues such as cancer, diabetes, and maternal health.

Columbia Bank Foundation

Since 1927, Columbia Bank has evolved alongside the communities and businesses we serve. What began as a single branch in Fair Lawn has grown into a regional bank serving New Jersey, Staten Island and Brooklyn. Throughout that growth, we have remained focused on providing the stability, convenience and service customers expect from a trusted financial partner. Today, we offer the strength and capabilities of a larger financial institution while continuing to provide the personal service and practical financial guidance that have long defined Columbia Bank.

Alongside Columbia Bank’s mission to serve the community, the Columbia Bank Foundation helps support local charitable causes and communities with grants on a sustained basis. Our goal is to make a difference in as many people’s lives as we can and to do our part to help make our communities better, stronger and safer.

Columbia Bank Foundation Micro Grants

The Columbia Bank Foundation is committed to serving the needs of its local communities. The Foundation actively seeks and focuses on innovative programs that provide a measurable impact in the communities that it serves.

Our Micro Grant Program allows organizations that meet one of our focus areas to apply for smaller grants under a streamlined application process. Applications under the Micro Grant Program will be accepted anytime throughout the year for $1,000 to $4,999. These are reviewed internally each month. Our Focus Areas:

• Housing Programs
• Community Investment and Economic Development Programs 
• Financial Literacy and Education 
• Health & Human Services
• Food Insecurity 
• Environmental Sustainability 
• The Arts

The Rural Communities Opioid Response Program (RCORP) - Community Systems Development aims to enhance behavioral health systems in rural areas by providing funding for the development and expansion of services. This initiative supports the establishment of formalized networks to boost operational and clinical capacity, ensuring effective implementation of evidence-based substance use disorder prevention, treatment, and recovery services tailored to community needs.

The National Institutes of Health (NIH) is dedicated to advancing emergency care through the Strategies to Innovate Emergency Care Clinical Trials Network (SIREN). This initiative seeks to establish clinical enrollment hubs that will enhance the network's ability to conduct trials aimed at improving outcomes for patients experiencing neurological and cardiovascular emergencies. Although applications are not currently being accepted, this notice encourages potential applicants to prepare collaborative and impactful proposals.

The National Institutes of Health (NIH) is seeking to enhance the Strategies to Innovate EmeRgENcy Care Clinical Trials Network (SIREN) through the establishment of a Clinical Coordinating Center (CCC) and Data Coordinating Center (DCC). This initiative aims to improve emergency care outcomes by supporting trials that focus on effective treatments for non-stroke neurological and cardiovascular emergencies. Although applications are not currently being solicited, this notice allows potential applicants to prepare collaborative proposals.

The Tribal Management Grant program is designed to empower tribes and tribal organizations by enabling them to take over functions and services of the Indian Health Service. Under the Public Law 93-638, this initiative aims to enhance their health management capabilities, fostering self-determination and improved healthcare delivery. The Indian Health Service plans to provide between five and sixteen awards to support this vital development in tribal health management.